In the Hospital de Pediatría Garrahan two patients are treated with the hepatitis acute of unknown origin, which has been registered in different countries and has health institutions on alert. In the last few hours, the Ministry of Health confirmed that adenovirus F41 was identified in those affected in Argentina.
One of the patients with hepatitis had to undergo a liver transplant, while experts try to determine a treatment to stop the progression of the illness. Adenovirus F41 was also confirmed by the CDC (Centers for Disease Control and Prevention) in patients treated in the United States.
The head of the Garrahan Hospital Epidemiological Control and Infectology Service, María Rosa Bologna, confirmed that the two patients with hepatitis presented adenovirus in their blood, which coincides with the international alert.